Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation
Javier A. Menendez, Inderjit Mehmi, Vishal A. Verma, Poh K. Teng, Ruth Lupu
Dive into the research topics of 'Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation'. Together they form a unique fingerprint.